329 related articles for article (PubMed ID: 16219020)
1. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.
Zelissen PM; Stenlof K; Lean ME; Fogteloo J; Keulen ET; Wilding J; Finer N; Rössner S; Lawrence E; Fletcher C; McCamish M;
Diabetes Obes Metab; 2005 Nov; 7(6):755-61. PubMed ID: 16219020
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans.
Fogteloo AJ; Pijl H; Frölich M; McCamish M; Meinders AE
Diabetes Nutr Metab; 2003 Apr; 16(2):109-14. PubMed ID: 12846450
[TBL] [Abstract][Full Text] [Related]
3. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
Kopelman P; Bryson A; Hickling R; Rissanen A; Rossner S; Toubro S; Valensi P
Int J Obes (Lond); 2007 Mar; 31(3):494-9. PubMed ID: 16953261
[TBL] [Abstract][Full Text] [Related]
4. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
5. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
Gadde KM; Parker CB; Maner LG; Wagner HR; Logue EJ; Drezner MK; Krishnan KR
Obes Res; 2001 Sep; 9(9):544-51. PubMed ID: 11557835
[TBL] [Abstract][Full Text] [Related]
6. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
Gadde KM; Yonish GM; Wagner HR; Foust MS; Allison DB
Int J Obes (Lond); 2006 Jul; 30(7):1138-42. PubMed ID: 16418753
[TBL] [Abstract][Full Text] [Related]
7. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Heymsfield SB; Greenberg AS; Fujioka K; Dixon RM; Kushner R; Hunt T; Lubina JA; Patane J; Self B; Hunt P; McCamish M
JAMA; 1999 Oct; 282(16):1568-75. PubMed ID: 10546697
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control.
Preuss HG; Garis RI; Bramble JD; Bagchi D; Bagchi M; Rao CV; Satyanarayana S
Int J Clin Pharmacol Res; 2005; 25(3):133-44. PubMed ID: 16366421
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
10. Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss.
Preuss HG; Bagchi D; Bagchi M; Rao CV; Dey DK; Satyanarayana S
Diabetes Obes Metab; 2004 May; 6(3):171-80. PubMed ID: 15056124
[TBL] [Abstract][Full Text] [Related]
11. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
[TBL] [Abstract][Full Text] [Related]
12. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
Albert SG; Haas MJ; Mooradian AD
Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
[TBL] [Abstract][Full Text] [Related]
13. Effects of very low calorie diet induced body weight loss with or without human pegylated recombinant leptin treatment on changes in ghrelin and adiponectin concentrations.
Lejeune MP; Hukshorn CJ; Saris WH; Westerterp-Plantenga MS
Physiol Behav; 2007 Jun; 91(2-3):274-80. PubMed ID: 17434547
[TBL] [Abstract][Full Text] [Related]
14. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
Belza A; Frandsen E; Kondrup J
Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
[TBL] [Abstract][Full Text] [Related]
15. Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss.
Trouillot TE; Pace DG; McKinley C; Cockey L; Zhi J; Häeussler J; Guerciolini R; Showalter R; Everson GT
Am J Gastroenterol; 2001 Jun; 96(6):1888-94. PubMed ID: 11421247
[TBL] [Abstract][Full Text] [Related]
16. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
17. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese.
Gaullier JM; Halse J; Høivik HO; Høye K; Syvertsen C; Nurminiemi M; Hassfeld C; Einerhand A; O'Shea M; Gudmundsen O
Br J Nutr; 2007 Mar; 97(3):550-60. PubMed ID: 17313718
[TBL] [Abstract][Full Text] [Related]
18. Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women.
Kuriyan R; Raj T; Srinivas SK; Vaz M; Rajendran R; Kurpad AV
Appetite; 2007 May; 48(3):338-44. PubMed ID: 17097761
[TBL] [Abstract][Full Text] [Related]
19. Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.
Näslund E; King N; Mansten S; Adner N; Holst JJ; Gutniak M; Hellström PM
Br J Nutr; 2004 Mar; 91(3):439-46. PubMed ID: 15005830
[TBL] [Abstract][Full Text] [Related]
20. Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial.
Anderson JW; Schwartz SM; Hauptman J; Boldrin M; Rossi M; Bansal V; Hale CA
Ann Pharmacother; 2006 Oct; 40(10):1717-23. PubMed ID: 16940406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
